NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Pernix Therapeutics Holdings, Inc. (AMEX: PTX)

 
PTX Technical Analysis
4
As on 31st Oct 2017 PTX Share Price closed @ 2.78 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.42 & Sell for SHORT-TERM with Stoploss of 2.91 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

PTX Share Price

Open 2.82 Change Price %
High 2.82 1 Day -0.04 -1.42
Low 2.75 1 Week 0.00 0.00
Close 2.78 1 Month -0.03 -1.07
Volume 41679 1 Year -1.16 -29.44
52 Week High 7.15 | 52 Week Low 1.83
 
AMEX USA Most Active Stocks
PAL 0.05 -50.00%
NGD 3.29 -6.80%
RBY 0.03 -70.00%
LODE 0.12 -7.69%
PBTH 8.23 0.37%
GGR 0.02 100.00%
VTG 0.05 -16.67%
SYRG 8.13 0.87%
GSX 0.02 0.00%
SHZ 0.10 -16.67%
 
AMEX USA Top Gainers Stocks
GGR 0.02 100.00%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
MBA 0.20 25.00%
MBA 0.20 25.00%
MBA 0.20 25.00%
IG 7.68 22.49%
IG 7.68 22.49%
 
AMEX USA Top Losers Stocks
RBY 0.03 -70.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
QBC 0.20 -33.33%
LBY 6.84 -25.33%
ATL 0.06 -25.00%
ATL 0.06 -25.00%
SNT 0.12 -20.00%
INV 0.14 -17.65%
 
 
PTX
Daily Charts
PTX
Intraday Charts
Whats New @
Bazaartrend
PTX
Free Analysis
 
PTX Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE2.84
RESISTANCE2.82
SUPPORT2.74
SUPPORT2.72
SUPPORT0.00
SUPPORT0.00
 
PTX Target for Month August
4th UP TARGET3.72
3rd UP TARGET3.42
2nd UP TARGET3.23
1st UP TARGET3.05
1st DOWN TARGET2.51
2nd DOWN TARGET2.33
3rd DOWN TARGET2.14
4th DOWN TARGET1.84
 
PTX Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
PTX Target for Year 2021
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
PTX Other Details
Segment EQ
Market Capital 220918032.00
Sector Healthcare
Industry Drug Manufacturers - Other
Offical website >
 
PTX Address
PTX
10863 Rockley Road
Houston, TX 77099
United States
Phone: 832-934-1825
Fax: 800-793-2145
 
PTX Latest News
 
Your Comments and Response on Pernix Therapeutics Holdings, Inc.
 
PTX Business Profile
Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells branded and generic pharmaceutical products. The company’s product include CEDAX, a oral cephalosporin used for the treatment of mild to moderate acute bacterial exacerbations of chronic bronchitis, middle ear infection due to haemophilus influenza, or streptococcus pyogene; REZIRA, ZUTRIPRO, and VITUZ, which are oral solutions for the relief of cough and nasal congestion; and OMECLAMOX-PAK to treat patients with H.pylori infection and duodenal ulcer disease. Its products also comprise SILENOR, a prescription medicine used to treat insomnia characterized by difficulty with sleep maintenance; KHEDEZLA, a prescription medicine for the treatment of major depressive disorder; and NATROBA, a prescription medicine used to treat head lice. In addition, the company offers various generic pharmaceutical products in the areas of nutritional supplements, analgesics, urinary tract, women’s health, pre-natal vitamins, and dental health, as well as allergy, respiratory, iron deficiency, nephrology, and pain management. It serves drug wholesalers, retail drug stores, mass merchandisers, and grocery store pharmacies in the United States. The company was founded in 1996 and is based in Houston, Texas.